145 related articles for article (PubMed ID: 26636524)
1. Effect and mechanism analysis of siRNA in inhibiting VEGF and its anti-angiogenesis effects in human osteosarcoma bearing rats.
Zhu XZ; Mei J
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(22):4362-70. PubMed ID: 26636524
[TBL] [Abstract][Full Text] [Related]
2. [Morphological changes in osteosarcoma xenografts in nude mice after inhibiting angiogenesis by Ad-VEGF-siRNA].
Wang JQ; Gao YS; Mei J; Xue HM; Wang SQ; Cai XS
Ai Zheng; 2009 Jun; 28(6):581-6. PubMed ID: 19635194
[TBL] [Abstract][Full Text] [Related]
3. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
[TBL] [Abstract][Full Text] [Related]
4. CCL3 promotes angiogenesis by dysregulation of miR-374b/ VEGF-A axis in human osteosarcoma cells.
Liao YY; Tsai HC; Chou PY; Wang SW; Chen HT; Lin YM; Chiang IP; Chang TM; Hsu SK; Chou MC; Tang CH; Fong YC
Oncotarget; 2016 Jan; 7(4):4310-25. PubMed ID: 26713602
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of VEGF-siRNA mediated by adenovirus on osteosarcoma-bearing nude mice.
Gao YS; Mei J; Tong TL; Hu M; Xue HM; Cai XS
Cancer Biother Radiopharm; 2009 Apr; 24(2):243-7. PubMed ID: 19409047
[TBL] [Abstract][Full Text] [Related]
6. [Expression of Ether à go-go 1 and its molecular mechanism of regulating the malignant phenotype of osteosarcoma].
Chen ZD; Liu QJ; Zeng WR; Wu XY; Lin B; Wu J
Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):818-825. PubMed ID: 27998439
[No Abstract] [Full Text] [Related]
7. [Inhibition of bladder cancer cell growth and angiogenesis by co-blockage of vascular endothelial growth factor and its receptor KDR].
Chen XL; Liu LC; Xu ZG; Li Z; Li RW; Gao RJ; Wang S; Zhang M; Guo H
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):578-82. PubMed ID: 19102933
[TBL] [Abstract][Full Text] [Related]
8. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
9. Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis.
Ding Y; Wang Y; Zhou J; Gu X; Wang W; Liu C; Bao X; Wang C; Li Y; Zhang Q
Biomaterials; 2014 Aug; 35(25):7214-27. PubMed ID: 24875759
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant multidrug chemotherapy including high-dose methotrexate modifies VEGF expression in osteosarcoma: an immunohistochemical analysis.
Rossi B; Schinzari G; Maccauro G; Scaramuzzo L; Signorelli D; Rosa MA; Fabbriciani C; Carlo B
BMC Musculoskelet Disord; 2010 Feb; 11():34. PubMed ID: 20158913
[TBL] [Abstract][Full Text] [Related]
11. The effects of RNA interference mediated VEGF gene silencing on biological behavior of renal cell carcinoma and transplanted renal tumor in nude mice.
Wang Q; Wang S; Sun SQ; Cheng ZH; Zhang Y; Chen G; Gu M; Yao HJ; Wang Z; Zhou J; Peng YB; Xu MX; Zhang K; Sun XW
Cancer Biomark; 2016; 16(1):1-9. PubMed ID: 26484606
[TBL] [Abstract][Full Text] [Related]
12. VEGF-siRNA silencing induces apoptosis, inhibits proliferation and suppresses vasculogenic mimicry in osteosarcoma in vitro.
Mei J; Gao Y; Zhang L; Cai X; Qian Z; Huang H; Huang W
Exp Oncol; 2008 Mar; 30(1):29-34. PubMed ID: 18438338
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of arsenic trioxide on angiogenesis and expression of vascular endothelial growth factor in gastric cancer.
Xiao YF; Liu SX; Wu DD; Chen X; Ren LF
World J Gastroenterol; 2006 Sep; 12(36):5780-6. PubMed ID: 17007042
[TBL] [Abstract][Full Text] [Related]
14. VEGF siRNA delivered by polycation liposome-encapsulated calcium phosphate nanoparticles for tumor angiogenesis inhibition in breast cancer.
Chen J; Sun X; Shao R; Xu Y; Gao J; Liang W
Int J Nanomedicine; 2017; 12():6075-6088. PubMed ID: 28860767
[TBL] [Abstract][Full Text] [Related]
15. Apurinic/apyrimidinic endonuclease 1 regulates angiogenesis in a transforming growth factor β-dependent manner in human osteosarcoma.
Jiang X; Shan J; Dai N; Zhong Z; Qing Y; Yang Y; Zhang S; Li C; Sui J; Ren T; Li M; Wang D
Cancer Sci; 2015 Oct; 106(10):1394-401. PubMed ID: 26250694
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of tumors cell growth in osteosarcoma-bearing SD rats through a combination of conventional and metronomic scheduling of neoadjuvant chemotherapy.
Zhu XZ; Yin HM; Mei J
Acta Pharmacol Sin; 2010 Aug; 31(8):970-6. PubMed ID: 20686521
[TBL] [Abstract][Full Text] [Related]
17. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
[TBL] [Abstract][Full Text] [Related]
18. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference.
Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM
J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596
[TBL] [Abstract][Full Text] [Related]
19. Gambogic acid inhibits angiogenesis through inhibiting PHD2-VHL-HIF-1α pathway.
Lu N; Hui H; Yang H; Zhao K; Chen Y; You QD; Guo QL
Eur J Pharm Sci; 2013 May; 49(2):220-6. PubMed ID: 23501055
[TBL] [Abstract][Full Text] [Related]
20. Proliferation inhibition and apoptosis promotion by dual silencing of VEGF and Survivin in human osteosarcoma.
Gu J; Ji Z; Li D; Dong Q
Acta Biochim Biophys Sin (Shanghai); 2019 Jan; 51(1):59-67. PubMed ID: 30566604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
